Hepatitis B virus infection: Prevention of mother-to-child transmission and exacerbation during pregnancy

Sasagawa, Yuki; Yamada, Hideto; Morizane, Mayumi; Deguchi, Masashi; Shirakawa, Tokuro; Morioka, Ichiro; Tanimura, Kenji

doi:10.1016/j.jiac.2019.03.014

Cited by 4 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the pre-COVID-19 study period (2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018)(2019), Japan newly introduced routine vaccinations for hepatitis B virus, HPV, pneumococcal infection, Hib infection, and varicella. Although the decreased trend in the burden of hepatitis B infection before the introduction of routine vaccination is likely because of other measures introduced well before the initiation of the routine vaccination [31][32][33], the reductions in the burdens of invasive pneumococcal disease by the 13-valent pneumococcal conjugate vaccine, invasive Hib disease and varicella support the effectiveness of these routine vaccinations with achieving high national coverage rates for these vaccines [19]. On the other hand, the reduction in the burdens of invasive pneumococcal disease by the 13-valent pneumococcal conjugate vaccine or the 23-valent pneumococcal polysaccharide vaccine was less remarkable compared with that by the 13-valent pneumococcal conjugate vaccine.…”

Section: Discussionmentioning

confidence: 99%

The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic

Kitano

2021

Journal of Infection and Chemotherapy

View full text Add to dashboard Cite

Background: Evaluating the national burdens across multiple vaccine-preventable diseases (VPDs) can be informative to identify the areas for improvements in the national immunization program. Methods: The annual burden of diseases from 2008 to 2020 in Japan were calculated with the incidence-and pathogen-based approach for the 15 VPDs (hepatitis B virus infection, human papillomavirus (HPV), influenza, invasive pneumococcal disease, invasive Haemophilus influenzae type b (Hib) disease, invasive meningococcal disease, Japanese encephalitis, measles, mumps, pertussis, rotavirus, rubella, tetanus, tuberculosis and varicella), using disability-adjusted life year (DALY). Results: The average annual burden between 2008 and 2020 is the highest in influenza (114,129 DALY/year), followed by HPV infection, hepatitis B virus infection, tuberculosis and mumps (109,782, 69,883, 23,855 and 5693 DALY/year). In the pre-COVID-19 period (2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017)(2018)(2019), the decreasing trend of burden was observed in hepatitis B virus infection, invasive pneumococcal disease, invasive Hib disease, tuberculosis and varicella. HPV infection is the only VPD which had more than 100,000 DALY/year for all years during the study period. In 2020, the estimated annual burdens are decreased in influenza (71%), invasive pneumococcal disease (51%), invasive Hib diseases (54%), invasive meningococcal disease (64%), measles (98%), mumps (47%) pertussis (83%), rotavirus infection (95%), rubella (94%) and varicella (35%) compared with those in 2019. Conclusions:The study demonstrated decreasing trends of burdens for some VPDs, while a persistently high burden has been observed for other VPDs, including HPV infection. The COVID-19 pandemic has caused dramatic reductions in the burdens of many VPDs in 2020.

show abstract

Section: Discussionmentioning

confidence: 99%

The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic

Kitano

2021

Journal of Infection and Chemotherapy

View full text Add to dashboard Cite

show abstract

“…Vaccination is a standard health care procedure for infants born from HBV infected mothers. 25 Passive and active immunization of infants born to HBsAgpositive mothers is the most important and effective way to prevent perinatal transmission of HBV infection. 19,20,26 The number of carriers among descendants is a good candidate to evaluate the effectiveness of the vaccination program.…”

Section: Discussionmentioning

confidence: 99%

Serological Features of Children Vertically Infected With Hepatitis B Virus: A Study in Amir Al-Momenin Ali Hospital of Zabol

Shahramian

Moradi

Ostadrahimi

et al. 2021

Int J Basic Sci Med

View full text Add to dashboard Cite

Introduction: Hepatitis B is a common viral infection worldwide and the main cause of chronic hepatitis, cirrhosis and liver cell carcinoma. hepatitis B e-antigen (HBeAg) is one of the markers indicating chronic hepatitis B infection. In this cross-sectional study, we investigate serological markers and HBeAg positivity in in children with maternally transmitted hepatitis B virus (HBV).Materials and Methods: Overall, 26 children with congenital HBV referred to Amir Al-Mo’menin Ali hospital in Zabol in 2019 and 2020 were enrolled. After gathering demographic characteristics, blood samples were taken from the patients. Serological tests were performed by routine ELISA tests. Data were analyzed using SPSS software version 22.Results: Twenty-six children were included in the study;18 of them (69.2%) were males. The mean age of the participants was 13.98±11 years (minimum of 1 and maximum of 18 years old). The mean age of mothers was 40.45±10 years (minimum of 27 and maximum of 63 years old). Four (15.4%) of the children were HBeAg positive, and 18 (69.2%) were HBeAb positive with no significant differences between genders (P > 0.05). HBeAg positivity was not associated with the birth rank (P = 0.71) or HBV vaccination (P = 0.17). Liver enzymes, serum albumin and children’s age and duration of maternal infection were not significantly different between HBeAg positive and HBeAg negative groups (P > 0.05). Mean serum alanine transaminase (ALT) was significantly higher in HBeAb positive than HBeAb negative children (P = 0.018), and HBeAb positivity was significantly associated with HBV vaccination history (P = 0.02). Other liver enzymes as well as age of mother and child and the duration of maternal infection were not significantly different between the two groups (P > 0.99). Conclusion: The prevalence of chronic HBV infection based on HBeAg positivity was relatively high in children vertically infected with the virus. HBeAb seroconversion seems to be associated with HBV vaccination.

show abstract

Hepatitis B surface antigen prevalence and the rates of mother-to-child transmission of hepatitis B virus after the introduction of infant vaccination programs in South East Asia and Western Pacific regions: a systematic review

Marjenberg¹,

Wright²,

Pooley³

et al. 2022

International Journal of Infectious Diseases

View full text Add to dashboard Cite

Hepatitis B virus infection: Prevention of mother-to-child transmission and exacerbation during pregnancy

Cited by 4 publications

References 15 publications

The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic

The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic

Serological Features of Children Vertically Infected With Hepatitis B Virus: A Study in Amir Al-Momenin Ali Hospital of Zabol

Hepatitis B surface antigen prevalence and the rates of mother-to-child transmission of hepatitis B virus after the introduction of infant vaccination programs in South East Asia and Western Pacific regions: a systematic review

Contact Info

Product

Resources

About